September 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
September 2026
The global general anesthesia drugs market size was calculated at USD 5.81 billion in 2026 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
September 2026
The global critical care drugs market size was evaluated at USD 1.28 billion in 2026 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
September 2026
The global oral oncology specialty pharmacy market is driven by rising cancer burden, increasing use of oral anticancer drugs, and expansion of specialty pharmacy services worldwide.
September 2026
The global expectorant drugs market size was evaluated at USD 19.56 billion in 2026 and is predicted to hit around USD 29.72 billion by 2035, growing at a CAGR of 4.76%.
September 2026
The global terbinafine hydrochloride drug market size was evaluated at USD 1.59 billion in 2026 and is predicted to hit around USD 3.43 billion by 2035, growing at a CAGR of 8.92%.
September 2026
The global antitussive drugs market size was evaluated at USD 1.81 billion in 2026 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The global non-oncology precision medicine market size is calculated at USD 101.25 billion in 2026 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
September 2026
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 7.62 billion in 2026 with a solid CAGR of 9.90%.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The global digital twin in oncology market size was evaluated at USD 594.00 million in 2026 and is predicted to hit around USD 7226.90 million by 2035, growing at a CAGR of 32.00%.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.17 billion in 2026 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
September 2026
The global pingueculum drugs market size was evaluated at USD 891.64 million in 2026 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
September 2026
The global sedative-hypnotic drugs market size was evaluated at USD 16.80 billion in 2026 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global antiepileptic drugs market size was evaluated at USD 19.02 billion in 2026 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 2.19 billion in 2026 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
September 2026
The global interventional oncology market size was evaluated at USD 3.19 billion in 2026 and is predicted to hit around USD 6.73 billion by 2035, growing at a CAGR of 8.63%.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com